As of 2025-07-07, the Relative Valuation of Wuhan Easy Diagnosis Biomedicine Co Ltd (002932.SZ) is 7.89 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 20.28 CNY, the upside of Wuhan Easy Diagnosis Biomedicine Co Ltd based on Relative Valuation is -61.1%.
The range of the Relative Valuation is 5.22 - 11.93 CNY.
| Range | Selected | |
| Trailing P/E multiples | 44.3x - 71.5x | 58.0x |
| Forward P/E multiples | 28.7x - 40.5x | 33.6x |
| Fair Price | 5.22 - 11.93 | 7.89 |
| Upside | -74.3% - -41.2% | -61.1% |
| Date | P/E |
| 2025-05-23 | 113.67 |
| 2025-05-22 | 113.85 |
| 2025-05-21 | 116.07 |
| 2025-05-20 | 116.25 |
| 2025-05-19 | 115.95 |
| 2025-05-16 | 113.55 |
| 2025-05-15 | 113.55 |
| 2025-05-14 | 114.57 |
| 2025-05-13 | 113.73 |
| 2025-05-12 | 113.37 |
| 2025-05-09 | 113.31 |
| 2025-05-08 | 114.69 |
| 2025-05-07 | 112.17 |
| 2025-05-06 | 113.97 |
| 2025-04-30 | 113.19 |
| 2025-04-29 | 111.81 |
| 2025-04-28 | 104.98 |
| 2025-04-25 | 108.40 |
| 2025-04-24 | 104.32 |
| 2025-04-23 | 102.88 |
| 2025-04-22 | 103.24 |
| 2025-04-21 | 102.52 |
| 2025-04-18 | 102.52 |
| 2025-04-17 | 102.82 |
| 2025-04-16 | 102.82 |
| 2025-04-15 | 104.68 |
| 2025-04-14 | 104.50 |
| 2025-04-11 | 104.14 |
| 2025-04-10 | 103.72 |
| 2025-04-09 | 101.93 |
| 2025-04-08 | 100.97 |
| 2025-04-07 | 101.27 |
| 2025-04-03 | 112.53 |
| 2025-04-02 | 113.19 |
| 2025-04-01 | 113.13 |
| 2025-03-31 | 108.40 |
| 2025-03-28 | 111.63 |
| 2025-03-27 | 112.83 |
| 2025-03-26 | 112.71 |
| 2025-03-25 | 111.99 |
| 2025-03-24 | 111.27 |
| 2025-03-21 | 113.97 |
| 2025-03-20 | 115.89 |
| 2025-03-19 | 117.32 |
| 2025-03-18 | 114.45 |
| 2025-03-17 | 113.43 |
| 2025-03-14 | 113.97 |
| 2025-03-13 | 111.39 |
| 2025-03-12 | 111.81 |
| 2025-03-11 | 112.89 |